Jen Robinson is the senior vice president of investor relations and corporate communications at Verve Therapeutics, bringing nearly 25 years of experience to her role. With 14 years dedicated to directing investor relations and corporate communications in the biotechnology sector, Jen has developed a deep expertise in strategic communications for life sciences companies. Prior to joining Verve, Jen served as vice president of investor relations and corporate communications at Deciphera Pharmaceuticals. She has held senior director of investor relations and corporate communications roles at Ra Pharmaceuticals, Ariad Pharmaceuticals, and Dyax Corp. Prior to her work in biotechnology, Jen worked as an equity research analyst on the buy-side, including at Putnam Investments, as well as a consultant liaison at Leerink Partners. 

Jen holds a B.A. in International and Comparative Politics from Dartmouth College.